TY - JOUR AU - Sheppard, P. AU - Kindsvogel, W. AU - Xu, W. PY - 2003 DA - 2003// TI - IL-28, IL-29 and their class II cytokine receptor IL-28R JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni873 DO - 10.1038/ni873 ID - Sheppard2003 ER - TY - JOUR AU - Kotenko, S. V. AU - Gallagher, G. AU - Baurin, V. V. PY - 2003 DA - 2003// TI - IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni875 DO - 10.1038/ni875 ID - Kotenko2003 ER - TY - JOUR AU - Langer, J. A. AU - Cutrone, E. C. AU - Kotenko, S. PY - 2004 DA - 2004// TI - The class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions JO - Cytokine Growth Factor Rev VL - 15 UR - https://doi.org/10.1016/j.cytogfr.2003.10.001 DO - 10.1016/j.cytogfr.2003.10.001 ID - Langer2004 ER - TY - JOUR AU - Pestka, S. AU - Krause, C. D. AU - Walter, M. R. PY - 2004 DA - 2004// TI - Interferons, interferon-like cytokines, and their receptors JO - Immunol Rev VL - 202 UR - https://doi.org/10.1111/j.0105-2896.2004.00204.x DO - 10.1111/j.0105-2896.2004.00204.x ID - Pestka2004 ER - TY - JOUR AU - Zeuzem, S. AU - Arora, S. AU - Bacon, B. PY - 2011 DA - 2011// TI - Pegylated interferon-lambda shows superior viral response with improved safety and tolerability versus PEGIFNalpha-2A in HCV (G1/2/3/4): emerge phase IIB through week 12 JO - J Hepatol VL - 54 UR - https://doi.org/10.1016/S0168-8278(11)61362-7 DO - 10.1016/S0168-8278(11)61362-7 ID - Zeuzem2011 ER - TY - JOUR AU - Gibbert, K. AU - Schlaak, J. F. AU - Yang, D. PY - 2013 DA - 2013// TI - IFN-α subtypes: distinct biological activities in anti-viral therapy JO - Br J Pharmacol VL - 168 UR - https://doi.org/10.1111/bph.12010 DO - 10.1111/bph.12010 ID - Gibbert2013 ER - TY - JOUR AU - Muir, A. J. AU - Shiffman, M. L. AU - Zaman, A. PY - 2010 DA - 2010// TI - Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection JO - Hepatology VL - 52 UR - https://doi.org/10.1002/hep.23743 DO - 10.1002/hep.23743 ID - Muir2010 ER - TY - JOUR AU - Cannella, F. AU - Scagnolari, C. AU - Selvaggi, C. PY - 2014 DA - 2014// TI - Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women JO - Med Microbiol Immunol VL - 203 UR - https://doi.org/10.1007/s00430-014-0330-9 DO - 10.1007/s00430-014-0330-9 ID - Cannella2014 ER - TY - JOUR AU - Koch, S. AU - Finotto, S. PY - 2015 DA - 2015// TI - Role of interferon-λ in allergic asthma JO - J Innate Immun VL - 7 UR - https://doi.org/10.1159/000369459 DO - 10.1159/000369459 ID - Koch2015 ER - TY - JOUR AU - Naumnik, W. AU - Naumnik, B. AU - Niewiarowska, K. PY - 2012 DA - 2012// TI - Novel cytokines: IL-27, IL-29, IL-31 and IL-33 can they be useful in clinical practice at the time diagnosis of lung cancer JO - Exp Oncol VL - 34 ID - Naumnik2012 ER - TY - JOUR AU - Cacciatore, J. J. AU - Chasin, L. A. AU - Leonard, E. F. PY - 2010 DA - 2010// TI - Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system JO - Biotechnol Adv VL - 28 UR - https://doi.org/10.1016/j.biotechadv.2010.04.003 DO - 10.1016/j.biotechadv.2010.04.003 ID - Cacciatore2010 ER - TY - JOUR AU - Peng, F. W. AU - Duan, Z. J. AU - Zheng, L. S. PY - 2007 DA - 2007// TI - Purification of recombinant human interferon-ε and oligonucleotide microarray analysis of interferon-ε regulated genes JO - Protein Expr Purif VL - 53 UR - https://doi.org/10.1016/j.pep.2006.12.013 DO - 10.1016/j.pep.2006.12.013 ID - Peng2007 ER - TY - JOUR AU - Hong, S. H. AU - Cho, O. AU - Kim, K. PY - 2007 DA - 2007// TI - Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells JO - Virus Res VL - 126 UR - https://doi.org/10.1016/j.virusres.2007.03.006 DO - 10.1016/j.virusres.2007.03.006 ID - Hong2007 ER - TY - JOUR AU - Miller, D. M. AU - Klucher, K. M. AU - Freeman, J. A. PY - 2009 DA - 2009// TI - Interferon lambda as a potential new therapeutic for hepatitis C JO - Ann N Y Acad Sci VL - 1182 UR - https://doi.org/10.1111/j.1749-6632.2009.05241.x DO - 10.1111/j.1749-6632.2009.05241.x ID - Miller2009 ER - TY - JOUR AU - Melchjorsen, J. AU - Siren, J. AU - Julkunen, K. PY - 2006 DA - 2006// TI - Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappa B and IRF-3 JO - J Gen Virol VL - 87 UR - https://doi.org/10.1099/vir.0.81541-0 DO - 10.1099/vir.0.81541-0 ID - Melchjorsen2006 ER - TY - JOUR AU - Bartlett, N. W. AU - Buttigieg, K. AU - Kotenko, S. V. PY - 2005 DA - 2005// TI - Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model JO - J Gen Virol VL - 86 UR - https://doi.org/10.1099/vir.0.80904-0 DO - 10.1099/vir.0.80904-0 ID - Bartlett2005 ER - TY - JOUR AU - Morrow, M. P. AU - Pankhong, P. AU - Laddy, D. J. PY - 2009 DA - 2009// TI - Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-11-190520 DO - 10.1182/blood-2008-11-190520 ID - Morrow2009 ER - TY - JOUR AU - Mordstein, M. AU - Neugebauer, E. AU - Ditt, V. PY - 2010 DA - 2010// TI - Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections JO - J Virol VL - 84 UR - https://doi.org/10.1128/JVI.00272-10 DO - 10.1128/JVI.00272-10 ID - Mordstein2010 ER - TY - JOUR AU - Ramos, E. L. PY - 2010 DA - 2010// TI - Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C JO - J Interf Cytokine Res VL - 30 UR - https://doi.org/10.1089/jir.2010.0066 DO - 10.1089/jir.2010.0066 ID - Ramos2010 ER - TY - JOUR AU - Contoli, M. AU - Message, S. D. AU - Laza-Stanca, V. PY - 2006 DA - 2006// TI - Role of deficient type III interferon-lambda production in asthma exacerbations JO - Nat Med VL - 12 UR - https://doi.org/10.1038/nm1462 DO - 10.1038/nm1462 ID - Contoli2006 ER - TY - JOUR AU - Zhu, J. PY - 2012 DA - 2012// TI - Mammalian cell protein expression for biopharmaceutical production JO - Biotechnol Adv VL - 30 UR - https://doi.org/10.1016/j.biotechadv.2011.08.022 DO - 10.1016/j.biotechadv.2011.08.022 ID - Zhu2012 ER -